Nanozymes Against Brain Tumors
Empa, Swiss Federal Laboratories for Materials Science and Technology
Brain tumors cannot always be successfully treated with conventional therapies. A team from Empa and the hospital network HOCH Health Ostschweiz is therefore developing nanozymes that can attack cancer cells directly in the brain during tumor surgery. The project can now be started thanks to the generous support of several foundations.